Wynne Elisabeth, Bergin James D, Ailawadi Gorav, Kern John A, Kennedy Jamie L W
School of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
J Card Surg. 2011 Nov;26(6):663-5. doi: 10.1111/j.1540-8191.2011.01331.x. Epub 2011 Oct 20.
Late stages of hypertrophic cardiomyopathy (HCM) result in medically refractory heart failure. Current treatments include septal myomectomy or alcohol ablation; however, not all patients are eligible for these procedures. We describe the technical aspects of implantation of a HeartMate II left ventricular assist device as a bridge to transplant therapy for a patient with HCM and end-stage heart failure. Pre- and post-operative imaging demonstrates the importance of establishing a functional inflow tract for the device.
肥厚型心肌病（HCM）晚期会导致药物难治性心力衰竭。目前的治疗方法包括室间隔肌切除术或酒精消融术；然而，并非所有患者都适合这些手术。我们描述了一名患有HCM和终末期心力衰竭患者植入HeartMate II左心室辅助装置作为移植治疗桥梁的技术细节。术前和术后成像显示了为该装置建立功能性流入道的重要性。
